Formulary evaluation of second-generation cephamycin derivatives using decision analysis.
Use of decision analysis in the formulary evaluation of the second-generation cephamycin derivatives cefoxitin, cefotetan, and cefmetazole is described. The rating system used was adapted from one used for the third-generation cephalosporins. Data on spectrum of activity, pharmacokinetics, adverse reactions, cost, and stability were taken from the published literature and the FDA-approved product labeling. The weighting scheme used for the third-generation cephalosporins was altered somewhat to reflect the more important aspects of the cephamycin derivatives and their potential role in surgical prophylaxis. Sensitivity analysis was done to assess the variability of the final scores when the assigned weights were varied within a reasonable range. Scores for cefmetazole and cefotetan were similar and did not differ significantly after sensitivity analysis. Cefoxitin scored significantly lower than the other two drugs. In the absence of data suggesting that the N-methyl thiotetrazole side chains of cefmetazole and cefotetan cause substantial toxicity, these two drugs can be considered the most cost-efficient members of the second-generation cephamycins.
Barriere
S L
SL
Department of Pharmaceutical Services, UCLA Medical Center 90024-6984.
D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D015311:Cefmetazole / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D015313:Cefotetan / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D002440:Cefoxitin / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D002513:Cephamycins / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D003661:Decision Support Techniques; D016527:Drug Costs; D004355:Drug Stability; D005572:Formularies, Hospital as Topic / Q000592:standards*; D006801:Humans; D010607:Pharmacy Service, Hospital / Q000458:organization & administration
D002513:Cephamycins; D015311:Cefmetazole; D015313:Cefotetan; D002440:Cefoxitin